China to tighten controls on fentanyl precursors in deal with U.S.

The United States and China have reached a tentative agreement to curb the flow of chemicals used to make fentanyl, marking a rare moment of cooperation between the two rivals.

Under the deal, Beijing will tighten export controls on thirteen precursor chemicals commonly used in the illicit production of fentanyl, the potent synthetic opioid blamed for tens of thousands of overdose deaths each year in the U.S.

The move follows months of negotiations aimed at choking off the supply chain that runs from Chinese chemical firms through Latin American cartels and into North America.

In return, Washington is preparing to reduce or suspend certain tariffs on Chinese industrial goods, in what officials described as a “balanced” approach linking trade incentives to progress on public health and law enforcement.

“China’s decision to restrict these exports is an important step toward saving lives on both sides of the Pacific,” a senior U.S. official said, adding that the agreement shows how the two countries “can work together on issues of shared concern.”

Chinese state media framed the move as part of a “joint commitment to safeguard global health and security,” emphasising Beijing’s willingness to cooperate internationally.

The deal comes as America continues to grapple with a devastating opioid epidemic.

Fentanyl and other synthetic opioids were linked to more than 70,000 American deaths last year, according to government data.

Washington has long accused Chinese suppliers of providing the raw materials later processed in Mexico and smuggled across the southern border.

The agreement builds on commitments made during the recent Trump-Xi summit, where both leaders pledged to revive cooperation on counternarcotics efforts.

While final details and enforcement mechanisms are still being worked out, officials on both sides say the initiative reflects an attempt to stabilise relations after years of trade and geopolitical friction.

If fully implemented, the pact could make a modest but tangible step toward rebuilding trust between Washington and Beijing and tackling one of the world’s most lethal public health crisis.

Copied